RESUMEN
Matrix stiffening with downstream activation of mechanosensitive pathways is strongly implicated in progressive fibrosis; however, pathologic changes in extracellular matrix (ECM) that initiate mechano-homeostasis dysregulation are not defined in human disease. By integrated multiscale biomechanical and biological analyses of idiopathic pulmonary fibrosis lung tissue, we identify that increased tissue stiffness is a function of dysregulated post-translational collagen cross-linking rather than any collagen concentration increase whilst at the nanometre-scale collagen fibrils are structurally and functionally abnormal with increased stiffness, reduced swelling ratio, and reduced diameter. In ex vivo and animal models of lung fibrosis, dual inhibition of lysyl oxidase-like (LOXL) 2 and LOXL3 was sufficient to normalise collagen fibrillogenesis, reduce tissue stiffness, and improve lung function in vivo. Thus, in human fibrosis, altered collagen architecture is a key determinant of abnormal ECM structure-function, and inhibition of pyridinoline cross-linking can maintain mechano-homeostasis to limit the self-sustaining effects of ECM on progressive fibrosis.
Asunto(s)
Aminoácido Oxidorreductasas/antagonistas & inhibidores , Colágeno/química , Inhibidores Enzimáticos/farmacología , Matriz Extracelular/química , Fibrosis Pulmonar/tratamiento farmacológico , Reticulina/química , Aminoácido Oxidorreductasas/genética , Aminoácido Oxidorreductasas/metabolismo , Aminoácidos/química , Animales , Fenómenos Biomecánicos , Estudios de Casos y Controles , Colágeno/metabolismo , Colágeno/ultraestructura , Reactivos de Enlaces Cruzados/química , Modelos Animales de Enfermedad , Matriz Extracelular/metabolismo , Matriz Extracelular/ultraestructura , Femenino , Fibroblastos/citología , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Expresión Génica , Homeostasis/genética , Humanos , Pulmón/metabolismo , Pulmón/patología , Mecanotransducción Celular , Procolágeno-Lisina 2-Oxoglutarato 5-Dioxigenasa/antagonistas & inhibidores , Procolágeno-Lisina 2-Oxoglutarato 5-Dioxigenasa/genética , Procolágeno-Lisina 2-Oxoglutarato 5-Dioxigenasa/metabolismo , Proteína-Lisina 6-Oxidasa , Fibrosis Pulmonar/genética , Fibrosis Pulmonar/metabolismo , Fibrosis Pulmonar/patología , Ratas , Ratas Sprague-Dawley , Reticulina/metabolismo , Reticulina/ultraestructura , Relación Estructura-Actividad , Factor de Crecimiento Transformador beta1/antagonistas & inhibidores , Factor de Crecimiento Transformador beta1/farmacologíaRESUMEN
TAFRO syndrome is a systemic inflammatory disorder manifesting as thrombocytopenia; anasarca including pleural effusion and ascites; fever; renal insufficiency; and organomegaly including hepatosplenomegaly and lymphadenopathy. Its onset may be acute or sub-acute, but its etiology remains unknown. Although several clinical and pathological characteristics of TAFRO syndrome resemble those of Castleman's disease, other specific features can differentiate between the two. Some patients have been successfully treated with glucocorticoids and/or immunosuppressants including cyclosporin A, tocilizumab and rituximab, whereas others are refractory to treatment, eventually succumbing to the disease. Early and reliable diagnoses and early treatments with appropriate agents are essential to enhancing patient survival. The 2015 updated diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, as formulated by Japanese research teams, are presented herein. Furthermore, clinicopathological data on 28 patients with this condition and similar symptoms (e.g., MCD with serositis and thrombocytopenia) were analyzed retrospectively.
Asunto(s)
Edema , Fiebre , Trombocitopenia , Edema/complicaciones , Edema/diagnóstico , Edema/terapia , Fiebre/complicaciones , Fiebre/diagnóstico , Fiebre/terapia , Fibrosis/complicaciones , Fibrosis/diagnóstico , Fibrosis/terapia , Humanos , Reticulina/química , Índice de Severidad de la Enfermedad , Trombocitopenia/complicaciones , Trombocitopenia/diagnóstico , Trombocitopenia/terapiaRESUMEN
X-linked thrombocytopenia with thalassemia (XLTT) is caused by the mutation 216R > Q in exon 4 of the GATA1 gene. Male hemizygous patients display macrothrombocytopenia, splenomegaly, and a ß-thalassemia trait. We describe two XLTT families where three males were initially misdiagnosed as having primary myelofibrosis (PMF) and all five investigated males showed mild-moderate bone marrow (BM) reticulin fibrosis. Comparative investigations were performed on blood samples and BM biopsies from males with XLTT, PMF patients and healthy controls. Like PMF, XLTT presented with high BM microvessel density, low GATA1 protein levels in megakaryocytes, and elevated blood CD34+ cell counts. But unlike PMF, the BM microvessel pericyte coverage was low in XLTT, and no collagen fibrosis was found. Further, as evaluated by immunohistochemistry, expressions of the growth factors VEGF, AGGF1, and CTGF were low in XLTT megakaryocytes and microvessels but high in PMF. Thus, although the reticulin fibrosis in XLTT might simulate PMF, opposing stromal and megakaryocyte features may facilitate differential diagnosis. Additional comparisons between these disorders may increase the understanding of mechanisms behind BM fibrosis in relation to pathological megakaryopoiesis.
Asunto(s)
Médula Ósea/patología , Enfermedades Genéticas Ligadas al Cromosoma X/diagnóstico , Neovascularización Patológica , Mielofibrosis Primaria/diagnóstico , Trombocitopenia/diagnóstico , Talasemia beta/diagnóstico , Adulto , Anciano , Proteínas Angiogénicas/genética , Proteínas Angiogénicas/metabolismo , Médula Ósea/metabolismo , Estudios de Casos y Controles , Factor de Crecimiento del Tejido Conjuntivo/genética , Factor de Crecimiento del Tejido Conjuntivo/metabolismo , Diagnóstico Diferencial , Fibrosis , Factor de Transcripción GATA1/genética , Factor de Transcripción GATA1/metabolismo , Expresión Génica , Enfermedades Genéticas Ligadas al Cromosoma X/complicaciones , Enfermedades Genéticas Ligadas al Cromosoma X/genética , Enfermedades Genéticas Ligadas al Cromosoma X/patología , Humanos , Leucocitos Mononucleares/metabolismo , Leucocitos Mononucleares/patología , Masculino , Megacariocitos/metabolismo , Megacariocitos/patología , Persona de Mediana Edad , Mutación , Linaje , Mielofibrosis Primaria/genética , Mielofibrosis Primaria/patología , Reticulina/química , Reticulina/metabolismo , Índice de Severidad de la Enfermedad , Trombocitopenia/complicaciones , Trombocitopenia/genética , Trombocitopenia/patología , Factor A de Crecimiento Endotelial Vascular/genética , Factor A de Crecimiento Endotelial Vascular/metabolismo , Talasemia beta/complicaciones , Talasemia beta/genética , Talasemia beta/patologíaRESUMEN
Essential thrombocythemia (ET) and primary myelofibrosis (PMF), together with polycythemia vera (PV) are Phildelphia-negative (Ph-neg) classical myeloproliferative neoplasms (MPN). ET has been traditionally identified by thrombocytosis and absence of relevant bone marrow (BM) fibrosis, while PMF by BM reticulin or collagen fibrosis with megakaryocyte hyperplasia and dysplasia, and extramedullary hematopoiesis. These diagnostic profiles have been challenged since 2001 when the World Health Organization (WHO) has included in the domain of PMF a new category of patients, namely early/prefibrotic MF, characterized by the absence of relevant reticulin fibrosis in BM, dual megakaryocyte and granulocyte proliferation, and megakaryocyte dysplasia. This review is focused on summarizing the diagnostic uncertainties of early/prefibrotic myelofibrosis, recent advances in our understanding of the biology of the variant, and the accompanying translational implications.
Asunto(s)
Janus Quinasa 2/genética , Subunidad p45 del Factor de Transcripción NF-E2/genética , Policitemia Vera/diagnóstico , Mielofibrosis Primaria/diagnóstico , Receptores de Trombopoyetina/genética , Trombocitemia Esencial/diagnóstico , Adulto , Células de la Médula Ósea/metabolismo , Células de la Médula Ósea/patología , Proliferación Celular , Colágeno/química , Colágeno/metabolismo , Diagnóstico Diferencial , Femenino , Humanos , Masculino , Persona de Mediana Edad , Mutación , Policitemia Vera/genética , Policitemia Vera/patología , Mielofibrosis Primaria/genética , Mielofibrosis Primaria/patología , Reticulina/química , Reticulina/metabolismo , Trombocitemia Esencial/genética , Trombocitemia Esencial/patologíaRESUMEN
The interruption of supraspinal input to the spinal cord leads to motor dysfunction and the development of spasticity. Clinical studies have shown that Baclofen (a GABAB agonist), while effective in modulating spasticity is associated with side-effects and the development of tolerance. The aim of the present study was to assess if discontinued Baclofen treatment and its repeated application leads antispasticity effects, and whether such changes affect neuronal nitric oxide synthase (nNOS) in the brainstem, nNOS and parvalbumin (PV) in lumbar α-motoneurons and glial fibrillary acidic protein in the ventral horn of the spinal cord. Adult male Wistar rats were exposed to Th9 spinal cord transection. Baclofen (30mg/b.w.) diluted in drinking water, was administered for 6 days, starting at week 1 after injury and then repeated till week 4 after injury. The behavior of the animals was tested (tail-flick test, BBB locomotor score) from 1 to 8 weeks. Our results clearly indicate the role of nitric oxide, produced by nNOS in the initiation and the maintenance of spasticity states 1, 6 and 8 weeks after spinal trauma. A considerable decrease of nNOS staining after Baclofen treatment correlates with improvement of motor dysfunction. The findings also show that parvalbumin and astrocytes participate in the regulation of ion concentrations in the sub-acute phase after the injury.
Asunto(s)
Baclofeno/farmacología , Baclofeno/uso terapéutico , Regulación de la Expresión Génica/efectos de los fármacos , Actividad Motora/efectos de los fármacos , Traumatismos de la Médula Espinal/tratamiento farmacológico , Animales , Inmunohistoquímica , Región Lumbosacra , Masculino , Neuronas Motoras/efectos de los fármacos , Neuronas/efectos de los fármacos , Óxido Nítrico Sintasa/metabolismo , Ratas , Ratas Wistar , Formación Reticular/efectos de los fármacos , Reticulina/química , Transducción de Señal/efectos de los fármacosRESUMEN
Cyclic shedding of the endometrium is unique to menstruating species. The status of the decidua in mouse menstrual-like models seems to differ from that of the predecidua in humans before endometrial breakdown. The aim of this study was to determine how this difference in decidual status is related to endometrial breakdown. A mouse menstrual-like model was generated by pharmacological progesterone withdrawal. Histomorphological analysis and reticular fiber staining were used to evaluate endometrial status. In situ zymography was used to determine the localization of active collagenase and gelatinase. The functional endometrial layer containing the mature decidual-like zone (MDZ) and predecidual-like zone (PZ) underwent breakdown. The reticular fibers underwent disruption and fragmentation and became loose or disappeared at 12 h in the PZ, where active collagenase and gelatinase were limited. The reticular fibers were visibly reduced at 24 h in the MDZ, where active collagenase was detected. A few reticular fibers remained; however, the functional layer had sloughed into the lumen of the uterus. The results showed that reticular fibers of the PZ are actively degraded during endometrial shedding.
Asunto(s)
Decidua/metabolismo , Endometrio/metabolismo , Menstruación/metabolismo , Animales , Benzofuranos , Colagenasas/metabolismo , Endometrio/citología , Endometrio/efectos de los fármacos , Endometrio/enzimología , Femenino , Gelatinasas/metabolismo , Ratones , Modelos Animales , Progesterona/farmacología , Progestinas/farmacología , Quinolinas , Reticulina/química , Coloración y EtiquetadoRESUMEN
Advances in the development of cornea substitutes by tissue engineering techniques have focused on the use of decellularized tissue scaffolds. In this work, we evaluated different chemical and physical decellularization methods on small intestine tissues to determine the most appropriate decellularization protocols for corneal applications. Our results revealed that the most efficient decellularization agents were the SDS and triton X-100 detergents, which were able to efficiently remove most cell nuclei and residual DNA. Histological and histochemical analyses revealed that collagen fibers were preserved upon decellularization with triton X-100, NaCl and sonication, whereas reticular fibers were properly preserved by decellularization with UV exposure. Extracellular matrix glycoproteins were preserved after decellularization with SDS, triton X-100 and sonication, whereas proteoglycans were not affected by any of the decellularization protocols. Tissue transparency was significantly higher than control non-decellularized tissues for all protocols, although the best light transmittance results were found in tissues decellularized with SDS and triton X-100. In conclusion, our results suggest that decellularized intestinal grafts could be used as biological scaffolds for cornea tissue engineering. Decellularization with triton X-100 was able to efficiently remove all cells from the tissues while preserving tissue structure and most fibrillar and non-fibrillar extracellular matrix components, suggesting that this specific decellularization agent could be safely used for efficient decellularization of SI tissues for cornea TE applications.
Asunto(s)
Córnea/cirugía , Intestino Delgado/citología , Ingeniería de Tejidos , Animales , Detergentes/química , Matriz Extracelular/química , Matriz Extracelular/trasplante , Matriz Extracelular/ultraestructura , Colágenos Fibrilares/química , Colágenos Fibrilares/ultraestructura , Glicoproteínas/química , Ratones , Octoxinol/química , Fenómenos Ópticos , Proteoglicanos/química , Reticulina/química , Reticulina/ultraestructura , Dodecil Sulfato de Sodio/química , Andamios del Tejido/química , Trasplante de Tejidos/métodosRESUMEN
A number of important biological tissues such as nacre, tendon, and bone consist of staggered structural arrays as universal motifs. Such arrays usually include stiff fibril-like (or plateletlike, or needlelike) elements embedded in an extrafibrillar (XF) phase. This work discusses the effect of the stiffness of such an XF matrix on the elastic properties of the resulting staggered composite. In the case of most biological composites, this XF stiffness is hardly accessible and very little data are available. We develop an analysis based on previous analytical formulation that results in a relation between the XF modulus and the deformations of the staggered particles. This analysis is then used to back-calculate the yet unmeasured modulus of the XF phase from experimental deformation data, thereby providing a simple alternative to potentially complex direct measurements. This is demonstrated and validated for parallel-fiber bone tissue.
Asunto(s)
Huesos/química , Matriz Extracelular/química , Modelos Biológicos , Reticulina/química , Fenómenos Biomecánicos , Huesos/anatomía & histología , Elasticidad , Tendones/anatomía & histología , Tendones/químicaRESUMEN
FKBP65 is a protein of the endoplasmic reticulum that is relatively abundant in elastin-producing cells and is associated with tropoelastin in the secretory pathway. To test an earlier suggestion by Davis and co-workers that FKBP65 could act as an intracellular chaperone for elastin, we obtained recombinant FKBP65 (rFKBP65) by expressing it in E. coli and examined its effect on the coacervation characteristics of chicken aorta tropoelastin (TE) using an in vitro turbidimetric assay. Our results reveal that rFKBP65 markedly promotes the initiation of coacervation of TE without significantly affecting the temperature of onset of coacervation. This effect shows saturation at a 1:2 molar ratio of TE to rFKBP65. By contrast, FKBP12, a peptidyl prolyl isomerase, has a negligible effect on TE coacervation. Moreover, the effect of rFKBP65 on TE coacervation is unaffected by the addition of rapamycin, an inhibitor of peptidyl prolyl isomerase (PPIase) activity. These observations rule out the involvement of the PPIase activity of rFKBP65 in modulating the coacervation of TE. Additional experiments using a polypeptide model of TE showed that rFKBP65, while promoting coacervation, may retard the maturation of this model polypeptide into larger aggregates. Based on these results, we suggest that FKBP65 may act as an elastin chaperone in vivo by controlling both the coacervation and the maturation stages of its self-assembly into fibrils.
Asunto(s)
Elastina/análisis , Elastina/metabolismo , Chaperonas Moleculares/química , Reticulina/química , Proteínas de Unión a Tacrolimus , Tropoelastina/química , Tropoelastina/metabolismo , Animales , Aorta/metabolismo , Pollos , Dicroismo Circular , Clonación Molecular , Elastina/química , Retículo Endoplásmico/metabolismo , Escherichia coli/genética , Escherichia coli/metabolismo , Humanos , Técnicas In Vitro , Ratones , Modelos Moleculares , Chaperonas Moleculares/genética , Chaperonas Moleculares/metabolismo , Isomerasa de Peptidilprolil/metabolismo , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Vías Secretoras/efectos de los fármacos , Sirolimus/farmacología , Proteínas de Unión a Tacrolimus/química , Proteínas de Unión a Tacrolimus/genética , Proteínas de Unión a Tacrolimus/metabolismo , Tropoelastina/genéticaRESUMEN
Chemokines orchestrate immune cell trafficking by eliciting either directed or random migration and by activating integrins in order to induce cell adhesion. Analyzing dendritic cell (DC) migration, we showed that these distinct cellular responses depended on the mode of chemokine presentation within tissues. The surface-immobilized form of the chemokine CCL21, the heparan sulfate-anchoring ligand of the CC-chemokine receptor 7 (CCR7), caused random movement of DCs that was confined to the chemokine-presenting surface because it triggered integrin-mediated adhesion. Upon direct contact with CCL21, DCs truncated the anchoring residues of CCL21, thereby releasing it from the solid phase. Soluble CCL21 functionally resembles the second CCR7 ligand, CCL19, which lacks anchoring residues and forms soluble gradients. Both soluble CCR7 ligands triggered chemotactic movement, but not surface adhesion. Adhesive random migration and directional steering cooperate to produce dynamic but spatially restricted locomotion patterns closely resembling the cellular dynamics observed in secondary lymphoid organs.
Asunto(s)
Movimiento Celular/inmunología , Quimiocinas/inmunología , Células Dendríticas/citología , Células Dendríticas/inmunología , Animales , Células Cultivadas , Células Inmovilizadas , Quimiocina CCL19/inmunología , Quimiocina CCL21/genética , Quimiocina CCL21/inmunología , Fluoroinmunoensayo , Integrinas/inmunología , Ganglios Linfáticos/inmunología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Receptores CCR7/inmunología , Proteínas Recombinantes/genética , Proteínas Recombinantes/inmunología , Reticulina/química , Solubilidad , Propiedades de SuperficieRESUMEN
Fibrous components of the extracellular matrix are light-microscopically classified into three types of fibers: collagen, reticular and elastic. The present study reviews the ultrastructure of these fibrous components as based on our previous studies by light, electron, and atomic force microscopy. Collagen fibers present a cord- or tape-shape 1-20 microm wide and run a wavy course in tissues. These fibers consist of closely packed thin collagen fibrils (30-100 nm thick in ordinary tissues of mammals), and exhibit splitting and joining in altering the number of the fibrils to form a three-dimensional network as a whole. Individual collagen fibrils (i.e., unit fibrils) in collagen fibers have a characteristic D-banding pattern whose length is ranges from 64 to 67 nm, depending on tissues and organs. During fibrogenesis, collagen fibrils are considered to be produced by fusing short and thin fibrils with tapered ends. Reticular fibers are usually observed as a delicate meshwork of fine fibrils stained black by the silver impregnation method. They usually underlie the epithelium and cover the surface of such cells of muscle cells, adipose cells and Schwann cells. Electronmicroscopically, reticular fibers are observed as individual collagen fibrils or a small bundle of the fibrils, although the diameter of the fibrils is thin (about 30 nm) and uniform. Reticular fibers are continuous with collagen fibers through the exchange of these collagen fibrils. In silver-impregnated specimens, individual fibrils in reticular fibers are densely coated with coarse metal particles, probably due to the high content of glycoproteins around the fibrils. Elastic fibers and laminae are composed of microfibrils and elastin components. Observations of the extracted elastin have revealed that elastin components are comprised of elastin fibrils about 0.1-0.2 microm thick. Elastic fibers and laminae are continuous with networks and/or bundles of microfibrils (or oxytalan fibers), and form an elastic network specific to individual tissues. The fibrous components of the extracellular matrix are thereby morphologically categorized into two systems: the collagen fibrillar system as a supporting framework of tissues and cells, and the microfibrilelastin system for uniformly distributing stress to maintain the resilience adapted to local tissue requirements.
Asunto(s)
Colágeno/química , Colágeno/ultraestructura , Elastina/química , Elastina/ultraestructura , Matriz Extracelular/química , Matriz Extracelular/ultraestructura , Reticulina/química , Reticulina/ultraestructura , Colágeno/metabolismo , Elastina/metabolismo , Matriz Extracelular/metabolismo , Humanos , Reticulina/metabolismoRESUMEN
BACKGROUND: The reticular framework of the white pulp (WP) and marginal zone (MZ) consists of reticulum cells and reticulin fibers. The antigenic heterogeneity of the reticular framework is well documented in the mouse and rat spleen. The aim of the present study is to characterize the reticular framework of the WP and MZ of the human spleen. METHODS: Nine surgically resected human spleens were investigated. Five of the nine spleens were perfused. Formalin-fixed materials were embedded in paraffin and serial sections prepared for hematoxylin-eosin, silver staining, and immunohistochemical examination. Electron and immuno-electron microscopy were also applied. Using confocal laser scanning microscopy, the reticular framework was analyzed three-dimensionally. RESULTS: The reticulin fibers of the framework were immunostained for type IV collagen in the WP and MZ. The WP was three-dimensionally delimited by the alpha-smooth muscle actin (alpha-SMA)-positive reticulum cells. In the WP, the distribution of alpha-SMA-positive reticulum cells formed the reticular framework of the periarteriolar lymphoid sheath (PALS). They also ensheathed the reticulin fibers. Interdigitating cells (IDCs) were scattered throughout the framework. A few IDCs attached to the framework. In the lymph follicle (LF), reticulum cells were not alpha-SMA-positive. The mesh of follicular dendritic cells (FDCs) was found in the germinal center. In places, the reticulin fibers were involved in the mesh of the FDCs and covered by the cytoplasm of FDCs. In the MZ, alpha-SMA-positive reticulum cells were arranged in a mesh pattern and ensheathed the fine reticulin fibers. CONCLUSION: The reticular framework of the PALS, LF, and MZ is specialized into heterogeneous components in the human spleen. The heterogeneity of the framework may induce the segregation of T and B lymphocytes.
Asunto(s)
Bazo/citología , Actinas/análisis , Adulto , Anciano , Arteriolas/química , Arteriolas/ultraestructura , Preescolar , Colágeno/análisis , Células Dendríticas/química , Células Dendríticas/ultraestructura , Femenino , Humanos , Inmunohistoquímica/métodos , Masculino , Microscopía Confocal , Microscopía Inmunoelectrónica , Persona de Mediana Edad , Reticulina/química , Reticulina/ultraestructura , Bazo/irrigación sanguínea , Bazo/químicaRESUMEN
Components were isolated from rat liver, sheep lung, rhesus and orang-utan intestine. In enzyme immunoassay, these components detected 57%, 72%, 84% and 88% of human sera containing endomysium and reticulin antibodies (EmA and ARA). At most, 7% of EmA/ARA-negative sera reacted with the antigens. The spectrum of EmA/ARA-positive sera reactive with the various components was different but overlapping. When the antigens of sheep lung and orang-utan intestine were used as a cocktail, 98% of EmA/ARA-positive sera (45/46), but only 2% of control sera (1/46) were detected. The isolated antigens from sheep lung and monkey intestines were able to absorb EmA and ARA from human sera and thus should be suspected to contain the epitopes recognized by EmA and ARA, whereas the rat liver component did not bind. Therefore, the spectrum of autoantibodies in coeliac disease might comprise more than that covered by the terms EmA and ARA. The N-terminal amino acid sequence of some of the antigens was homologous with casein, gliadin, fibrinogen, and collagen.